An unsolicited bid by private equity group CVC to take control of Italian pharma company Recordati looks likely to come off, ...
Two months after saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement ...
Biogen and Denali have now confirmed that the results show BIIB122 (also known as DNL151) did not slow the progression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results